Max Rosett insider trades
Open-market stock purchases and sales by Max Rosett, Chief Financial Officer at Immunome Inc, from SEC Form 4 filings since Jan 31, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 23, 2026 | IMNM Immunome Inc | Bought (not open market) | — |
| Jul 23, 2026 | IMNM Immunome Inc | Bought (not open market) | — |
| Jun 15, 2026 | IMNM Immunome Inc | Sold | $1.1M |
| Jun 15, 2026 | IMNM Immunome Inc | Bought (not open market) | — |
| Apr 2, 2026 | IMNM Immunome Inc | Sold | $1.4M |
| Apr 2, 2026 | IMNM Immunome Inc | Sold | $30.2K |
| Apr 2, 2026 | IMNM Immunome Inc | Bought (not open market) | — |
| Apr 2, 2026 | IMNM Immunome Inc | Bought (not open market) | — |
Companies traded
- IMNM Immunome Inc: 4 sales, last Jul 23, 2026